ABCC8 p.Ala30Val
Predicted by SNAP2: | C: N (57%), D: D (66%), E: D (66%), F: D (66%), G: N (87%), H: D (63%), I: N (78%), K: N (57%), L: D (59%), M: D (59%), N: D (59%), P: N (53%), Q: D (59%), R: D (63%), S: N (93%), T: N (93%), V: N (78%), W: D (53%), Y: D (66%), |
Predicted by PROVEAN: | C: N, D: D, E: D, F: D, G: N, H: D, I: N, K: N, L: N, M: N, N: D, P: D, Q: N, R: N, S: N, T: N, V: N, W: D, Y: D, |
[switch to compact view]
Comments [show]
None has been submitted yet.
[hide] Compound heterozygous mutations in the SUR1 (ABCC ... Channels (Austin). 2012 Mar-Apr;6(2):133-8. doi: 10.4161/chan.19980. Epub 2012 Mar 1. Lin YW, Akrouh A, Hsu Y, Hughes N, Nichols CG, De Leon DD
Compound heterozygous mutations in the SUR1 (ABCC 8) subunit of pancreatic K(ATP) channels cause neonatal diabetes by perturbing the coupling between Kir6.2 and SUR1 subunits.
Channels (Austin). 2012 Mar-Apr;6(2):133-8. doi: 10.4161/chan.19980. Epub 2012 Mar 1., [PMID:22562119]
Abstract [show]
KATP channels regulate insulin secretion by coupling beta-cell metabolism to membrane excitability. These channels are comprised of a pore-forming Kir6.2 tetramer which is enveloped by four regulatory SUR1 subunits. ATP acts on Kir6.2 to stabilize the channel closed state while ADP (coordinated with Mg(2+)) activates channels via the SUR1 domains. Aberrations in nucleotide-binding or in coupling binding to gating can lead to hyperinsulinism or diabetes. Here, we report a case of diabetes in a 7-mo old child with compound heterozygous mutations in ABCC8 (SUR1[A30V] and SUR1[G296R]). In unison, these mutations lead to a gain of KATP channel function, which will attenuate the beta-cell response to increased metabolism and will thereby decrease insulin secretion. (86)Rb(+) flux assays on COSm6 cells coexpressing the mutant subunits (to recapitulate the compound heterozygous state) show a 2-fold increase in basal rate of (86)Rb(+) efflux relative to WT channels. Experiments on excised inside-out patches also reveal a slight increase in activity, manifested as an enhancement in stimulation by MgADP in channels expressing the compound heterozygous mutations or homozygous G296R mutation. In addition, the IC 50 for ATP inhibition of homomeric A30V channels was increased ~6-fold, and was increased ~3-fold for both heteromeric A30V+WT channels or compound heterozygous (A30V +G296R) channels. Thus, each mutation makes a mechanistically distinct contribution to the channel gain-of-function that results in neonatal diabetes, and which we predict may contribute to diabetes in related carrier individuals.
Comments [show]
None has been submitted yet.
No. Sentence Comment
8 Here, we report a case of diabetes in a 7-mo old child with compound heterozygous mutations in ABCC8 (SUR1[A30V] and SUR1[G296R]).
X
ABCC8 p.Ala30Val 22562119:8:107
status: NEW12 In addition, the IC50 for ATP inhibition of homomeric A30V channels was increased ~6-fold, and was increased ~3-fold for both heteromeric A30V + WT channels or compound heterozygous (A30V + G296R) channels.
X
ABCC8 p.Ala30Val 22562119:12:54
status: NEWX
ABCC8 p.Ala30Val 22562119:12:138
status: NEWX
ABCC8 p.Ala30Val 22562119:12:183
status: NEW32 Direct sequencing of his DNA revealed two mutations in the ABCC8 gene c.886 G > A (G296R) and c.89 C > T (A30V), the first of which is maternally derived and the second is paternally derived.
X
ABCC8 p.Ala30Val 22562119:32:106
status: NEW41 As shown in Figure 1A, neither heteromeric single mutant channels ([A30V + WT], referred to as hetA30V and [G296R + WT], referred to as hetG296R) nor compound heterozygous channels ([A30V + G296R]) exhibited significantly different maximum 86 Rb+ efflux rates in the presence of metabolic inhibitors.
X
ABCC8 p.Ala30Val 22562119:41:68
status: NEWX
ABCC8 p.Ala30Val 22562119:41:183
status: NEW53 k2,basal /k2,MI calculated from WT, het A30V, het G296R and SUR1[A30V + G296R] are 0.07 &#b1; 0.005, 0.08 &#b1; 0.01, 0.1 &#b1; 0.01 and 0.16 &#b1; 0.01 (n = 4-9).
X
ABCC8 p.Ala30Val 22562119:53:40
status: NEWX
ABCC8 p.Ala30Val 22562119:53:65
status: NEW56 Homozygous G296R channels exhibit a slightly right-shifted dose-response, but homozygous A30V channels exhibit a marked and significantly right-shifted ATP sensitivity (Fig. 4B).
X
ABCC8 p.Ala30Val 22562119:56:89
status: NEW57 In the heteromeric case, mimicking the disease condition, hetG296R channels are not markedly different from WT, but hetA30V and compound heterozygous A30V + G296R channels both exhibit a significant rightward shift when compared with WT channels (Fig. 4C).
X
ABCC8 p.Ala30Val 22562119:57:150
status: NEW64 A30V and G296R mutants are located at the TMD0 and the cytosolic linker region (L0) of SUR1 3 (Fig. 2).
X
ABCC8 p.Ala30Val 22562119:64:0
status: NEW66 Here we characterized the sensitivity to MgADP activation, as well as inhibitory ATP sensitivity (without Mg2+ ), of homomeric A30V channels (labeled as homA30V), homomeric G296R channels (labeled as homG296R), hetA30V, hetG296R and compound heterozygous channels [A30V + G296R].8,18,19 Representative recordings of channel response to MgADP from WT and compound heterozygous mutants are shown in Figure 3A and summary results are shown in Figure 3B.
X
ABCC8 p.Ala30Val 22562119:66:127
status: NEWX
ABCC8 p.Ala30Val 22562119:66:265
status: NEW67 Homomeric G296R channels exhibit dramatically increased MgADP activity, while homomeric A30V channels show no significant enhancement (Fig. 3B).
X
ABCC8 p.Ala30Val 22562119:67:88
status: NEW69 On the other hand, it is noticeable that A30V homomeric channels show significant increased current in 0.1 mM MgATP, reflecting an additive consequence of the two distinct mutant effects (Fig. 3B).
X
ABCC8 p.Ala30Val 22562119:69:41
status: NEW71 Given that homomeric A30V channels showed greatly reduced ATP sensitivity in 0.1 mM ATP (with 0.5 mM free Mg2+ ), we characterized the sensitivity to inhibitory ATP, without any confounding effects of Mg-nucleotides.
X
ABCC8 p.Ala30Val 22562119:71:21
status: NEW74 Membrane topology of SUR1 and the predicted locations of A30V and 296R.
X
ABCC8 p.Ala30Val 22562119:74:57
status: NEW75 The red filled circles indicate the predicted positions for A30V at the N terminus of its 1st transmembrane domain (TMD0) and G296R at the L0 linker region before TMD1 domain.
X
ABCC8 p.Ala30Val 22562119:75:60
status: NEW79 Representative inside-out patch clamp recordings of WT and A30V + G296R in different MgATP and MgADP concentrations (A).
X
ABCC8 p.Ala30Val 22562119:79:59
status: NEW81 (B) Relative channel currents in 0.1 mM MgATP and plus 0.5 mM MgADP for WT, homA30V, homG296R, hetA30V, hetG296R and compound heterozygous [A30V + G296R] channels as indicated.
X
ABCC8 p.Ala30Val 22562119:81:140
status: NEW92 (A) Representative currents recorded by inside-out excised patch-clamp technique from COSm6 cells expressing WT, homA30V, homG296R and [A30V + G296R] at +50 mV pipette potential. Patches were exposed to different concentrations of Mg-free ATP as indicated.
X
ABCC8 p.Ala30Val 22562119:92:136
status: NEW96 Fitted K1/2 for WT, homA30V and homG296R channels are 9.65, 53.31 and 28.11 (in bc;M) and the Hill coefficients are 1.22, 1.04 and 1.19, respectively. (C) The fitted K1/2 for WT, hetA30V, hetG296R and [A30V + G296R] are 9.65, 25.75, 12.75 and 25.45 (in bc;M) and the Hill coefficients are 1.22, 1.28, 1.29 and 1.23, respectively. from the child and both parents.
X
ABCC8 p.Ala30Val 22562119:96:205
status: NEW98 Two mutations were found in ABCC8 in the proband: c.886 G > A, predicted to cause a G296R amino acid change, was maternally transmitted, and c.89 C > T, predicted to cause A30V amino acid change, was paternally transmitted.
X
ABCC8 p.Ala30Val 22562119:98:172
status: NEW125 (A) Representative currents recorded by inside-out excised patch-clamp technique from COSm6 cells expressing WT and [A30V + G296R] at +50 mV pipette potential. Patches were exposed to different concentrations of glibenclamide as indicated (free Mg-nucleotide).
X
ABCC8 p.Ala30Val 22562119:125:117
status: NEW